Home Artificial Intelligence Chinese Digital Powerhouse Moves into Clinical AI to Improve Parkinson’s Disease

Chinese Digital Powerhouse Moves into Clinical AI to Improve Parkinson’s Disease

478
2

South China Morning Post reports Tencent is scouring the world for partners in revolutionizing medicine. Tencent seeks to leverage its advantage in AI to improve Parkinson’s disease treatment. By teaming with British-based Medopad (founded in 2011), the partners seek to develop a remote monitoring system for patients with severe movement disorders. There ultimate goal is to support patient-centric clinical care—by enabling physicians to set drug doses and modify care without patients coming into the hospital. Medopad has received investment from German pharmaceutical company Bayer and reports they have signed $131 million worth of deals including Chinese-based Tencent.

2 COMMENTS

  1. Do you mind if I quote a few of your articles as long
    as I provide credit and sources back to your webpage?
    My blog is in the very same area of interest
    as yours and my users would certainly benefit from some of the information you present here.
    Please let me know if this ok with you. Thanks a lot!

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.